Recent transactions
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Barone Francesca | Chief Scientific Officer | S Sale | — | $10.06 | $236K | filing |
| Jul 1, 2026 | Tyagarajan Seshu | CTO | S Sale | — | $10.02 | $70K | filing |
CANDEL THERAPEUTICS (CADL) insider trades
CANDEL THERAPEUTICS (CADL) insider trading activity (SEC Form 4). Over the trailing 90 days, CADL insiders filed 0 purchases totalling $0 and 2 sales totalling $306K — net SELLING of $306K. Most recent filing: Jul 1, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
2
$306K
Net (90d)
-$306K
net selling
Most recent
Jul 1, 2026